Biocon Biologics receives observations from USFDA: Biocon

The USFDA conducted three on-site inspections of Biocon Biologics' seven manufacturing facilities spanning two sites in Bengaluru, India and one at Johor, Malaysia, Biocon said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/QlaNbnU
via IFTTT